AmSurg Corp (AMSG)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AmSurg Corp (AMSG) trades at $67.75 with AI Score 62/100 (Grade B+). AmSurg Corp (AMSG) operates ambulatory surgery centers (ASCs) and provides physician services, specializing in surgical procedures performed outside traditional hospital settings. Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for AMSG: AMSG does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMSG against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
AMSG: 2/3 perspectives are bullish. Dominant signal: Moon AI bullish.
How is this calculated? →AmSurg Corp (AMSG) Healthcare & Pipeline Overview
AmSurg Corp is a leading provider of ambulatory surgery center services and physician support, focusing on delivering cost-effective, convenient outpatient surgical care. The company leverages its significant market presence in the ASC sector to capitalize on the ongoing shift from inpatient to outpatient surgical procedures, enhancing patient access and operational efficiency.
What Is the Investment Thesis for AMSG?
AmSurg Corp presents an investment thesis centered on its robust position within the growing ambulatory surgery center (ASC) market and its strategic alignment with the healthcare industry's shift towards outpatient care. The company's business model, focused on cost-effective and convenient surgical options, positions it favorably against traditional inpatient settings. AMSG's financial profile indicates a P/E ratio of 19.98, a profit margin of 6.3%, and a gross margin of 100.0%, reflecting operational efficiency in its service delivery. The company's Beta of 0.74 suggests lower volatility compared to the broader market. Key growth catalysts include the ongoing demographic shift towards an aging population requiring more surgical interventions and the increasing preference by both patients and payers for lower-cost outpatient procedures. However, investors must monitor potential risks such as reimbursement pressures from government and private payers, which could impact operational profitability, and the evolving regulatory landscape that may introduce new compliance challenges or payment models. The ability of AmSurg to effectively manage these pressures while expanding its network and service offerings will be critical to its sustained value creation.
Based on FMP financials and quantitative analysis
AMSG Key Highlights
- P/E ratio of 19.98, indicating market valuation relative to earnings.
- Profit Margin of 6.3%, reflecting the company's profitability from its core operations.
- Gross Margin of 100.0%, suggesting highly efficient service delivery before operating expenses.
- Beta of 0.74, indicating lower stock price volatility compared to the overall market.
- Significant position in the ambulatory surgery center (ASC) market, capitalizing on the shift towards outpatient surgical settings.
What Are AMSG's Key Strengths?
- Significant market position in the ambulatory surgery center (ASC) sector.
- Offers cost-effective and convenient surgical options compared to hospitals.
- Beneficiary of the increasing shift towards outpatient surgical settings.
- High gross margin of 100.0% indicating efficient service delivery.
What Are AMSG's Weaknesses?
- Vulnerable to reimbursement pressures from government and private payers.
- Dependent on regulatory changes in the healthcare landscape.
- Lack of dividend yield may deter income-focused investors.
- Operational profitability can be impacted by evolving healthcare dynamics.
What Could Drive AMSG Stock Higher?
- Favorable regulatory adjustments that expand the list of procedures eligible for reimbursement in ASCs by major payers, potentially increasing procedure volume and revenue per case.
- Continued acceleration of the healthcare industry's shift towards outpatient surgical settings, driven by cost-containment initiatives and patient preferences for convenience and lower infection risk.
- Successful integration of new technologies or surgical techniques that allow for more complex procedures to be safely and efficiently performed in an outpatient environment, expanding AmSurg's service offerings.
- Strategic partnerships or acquisitions that enhance AmSurg's geographic footprint or expand its specialty service lines, leading to increased market share and operational synergies.
What Are the Key Risks for AMSG?
- Persistent reimbursement pressures from government programs (e.g., Medicare, Medicaid) and private insurance payers, which could lead to reduced payment rates for services and compress profit margins.
- Adverse regulatory changes or new healthcare legislation that could impose stricter operational requirements, increase compliance costs, or alter payment models for ambulatory surgery centers.
- Evolving competitive landscape, including increased investment by hospital systems in their own outpatient facilities, potentially diverting patient volumes from AmSurg's ASCs.
- Shortages of skilled healthcare professionals, such as surgeons, anesthesiologists, and nurses, which could increase labor costs or limit the capacity of AmSurg's facilities to perform procedures.
- Economic downturns or changes in consumer spending habits that could lead to a decrease in elective surgical procedures, impacting AmSurg's revenue generation.
What Are the Growth Opportunities for AMSG?
- Growth opportunity 1: **Continued Shift to Outpatient Care:** The healthcare industry is experiencing a significant and accelerating trend towards performing surgical procedures in outpatient settings rather than traditional hospitals. This shift is driven by cost efficiencies, improved patient outcomes, and patient preference for convenience. AmSurg, with its established network of ambulatory surgery centers (ASCs), is directly positioned to benefit from this macro trend. The outpatient surgery market is projected to continue expanding, offering a substantial addressable market for AMSG to grow its volume of procedures and expand its geographic footprint over the next 5-10 years.
- Growth opportunity 2: **Aging Population and Increased Demand for Procedures:** The global population is aging, particularly in developed economies, leading to a higher incidence of age-related conditions requiring surgical intervention. This demographic shift inherently increases the demand for various surgical procedures, from ophthalmology to orthopedics. AmSurg's focus on a broad range of surgical specialties within its ASCs allows it to cater to this growing patient demographic. This sustained demand provides a long-term growth driver, ensuring a consistent need for the cost-effective and accessible services offered by AMSG.
- Growth opportunity 3: **Expansion into New Geographic Markets:** While AmSurg holds a significant position, there remain untapped or underserved geographic regions where the ASC model can be successfully implemented. Strategic expansion into new states or metropolitan areas, either through de novo development or acquisition of existing facilities, represents a tangible growth pathway. This allows AmSurg to broaden its patient reach, diversify its revenue streams, and establish new partnerships with local physician groups, extending its operational footprint and market influence over the medium term.
- Growth opportunity 4: **Strategic Acquisitions and Partnerships:** The ambulatory surgery center market is somewhat fragmented, presenting opportunities for consolidation. AmSurg can pursue strategic acquisitions of smaller, independent ASCs or physician practices to expand its network, gain market share, and achieve economies of scale. Additionally, forming partnerships with large hospital systems or integrated delivery networks can enhance referral pathways and operational synergies. These inorganic growth strategies can accelerate market penetration and strengthen AmSurg's competitive position within the next 3-7 years.
- Growth opportunity 5: **Diversification of Service Offerings and Procedure Mix:** As medical technology advances, an increasing number of complex surgical procedures can be safely performed in an outpatient setting. AmSurg has the opportunity to expand its service offerings beyond traditional procedures to include more advanced or specialized surgeries. This diversification can attract a wider range of specialists and patients, increasing the average revenue per procedure and enhancing the overall utilization of its ASC facilities. Adapting to evolving medical practices and expanding the scope of treatable conditions in ASCs represents a continuous growth avenue for the company.
What Opportunities Does AMSG Have?
- Continued growth in demand for outpatient surgical procedures due to cost and convenience.
- Aging population driving increased need for surgical interventions.
- Potential for strategic acquisitions to expand network and market share.
- Diversification into new surgical specialties or more complex outpatient procedures.
What Threats Does AMSG Face?
- Adverse regulatory changes impacting ASC operations or reimbursement rates.
- Intensified competition from hospital outpatient departments and other ASC providers.
- Economic downturns potentially impacting elective procedure volumes.
- Staffing shortages or rising labor costs in the healthcare sector.
What Are AMSG's Competitive Advantages?
- Established network and scale of ambulatory surgery centers, creating operational efficiencies.
- Strong physician partnerships and integrated service models, fostering loyalty and referrals.
- Expertise in navigating complex healthcare regulations and reimbursement landscapes.
- Cost advantage over traditional hospital settings for many surgical procedures.
- Reputation for quality and patient satisfaction in outpatient surgical care.
What Does AMSG Do?
AmSurg Corp (AMSG) is a prominent entity in the healthcare services sector, primarily operating ambulatory surgery centers (ASCs) and providing comprehensive physician services. The company's core business revolves around facilitating surgical procedures in outpatient settings, which are distinct from traditional hospital environments. This model emphasizes efficiency, cost-effectiveness, and patient convenience, positioning AMSG as a key player in the evolving landscape of healthcare delivery. AmSurg's operations encompass a wide range of surgical specialties, allowing it to serve diverse patient needs while supporting a broad network of physicians. The company's strategic focus on ASCs addresses the growing demand for accessible and affordable surgical options, a trend driven by both payer preferences and patient expectations. By managing and partnering with physician groups, AmSurg ensures high-quality care delivery within its facilities. Its significant market position in the ASC segment is a testament to its operational expertise and ability to navigate the complex regulatory and reimbursement frameworks of the healthcare industry. The company continually adapts its service offerings and operational strategies to align with healthcare trends, particularly the increasing shift towards outpatient surgical settings, which offers a compelling value proposition to both patients and the broader healthcare system.
What Products and Services Does AMSG Offer?
- Operate and manage ambulatory surgery centers (ASCs) across various specialties.
- Provide physician services, supporting medical professionals in outpatient surgical settings.
- Offer cost-effective alternatives to traditional hospital-based surgical procedures.
- Facilitate a wide range of surgical specialties, including ophthalmology, gastroenterology, orthopedics, and pain management.
- Partner with physicians to ensure high-quality patient care and operational efficiency in ASCs.
- Focus on delivering convenient and accessible surgical options for patients.
- Manage the administrative and operational aspects of surgical facilities.
How Does AMSG Make Money?
- Generate revenue through facility fees for surgical procedures performed in its ambulatory surgery centers.
- Earn income from contracts for physician services, supporting medical practices.
- Benefit from partnerships with insurance companies and government payers for reimbursement of services.
- Achieve profitability through operational efficiencies and high utilization rates of its ASC facilities.
What Industry Does AMSG Operate In?
AmSurg Corp operates within the dynamic healthcare services industry, specifically targeting the ambulatory surgery center (ASC) market. This sector is characterized by a significant and ongoing shift from traditional inpatient hospital care to more cost-effective and convenient outpatient settings. Market trends indicate a growing preference among payers and patients for ASCs due to lower procedure costs, reduced infection rates, and enhanced patient experience. AmSurg holds a notable position in this competitive landscape, leveraging its network of ASCs and physician services to capture market share. The industry is influenced by demographic shifts, such as an aging population requiring more surgical interventions, and technological advancements that enable more complex procedures to be performed safely in outpatient environments. Regulatory changes and reimbursement policies from government and private payers are critical factors shaping the operational and financial viability of companies in this space, creating both opportunities and challenges for AmSurg.
Who Are AMSG's Key Customers?
- Patients seeking outpatient surgical procedures.
- Physicians and surgeon groups who utilize AmSurg's facilities and services.
- Private health insurance companies and managed care organizations.
- Government healthcare programs, such as Medicare and Medicaid.
- Referring primary care physicians and specialists.
ROE 8%Key Financial Metrics
Return on equity for AmSurg Corp stands at 8.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.5%, showing how much profit it generates from its asset base. AMSG trades at a trailing price-to-earnings ratio of 19.98, below the Healthcare sector average of ~23x. A current ratio of 1.37 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.0%, the inverse of the P/E and a quick read on earnings relative to price.
AMSG Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Significant market position in the ambulatory surgery center (ASC) sector.
- Offers cost-effective and convenient surgical options compared to hospitals.
- Beneficiary of the increasing shift towards outpatient surgical settings.
- High gross margin of 100.0% indicating efficient service delivery.
Bear Case
- Vulnerable to reimbursement pressures from government and private payers.
- Dependent on regulatory changes in the healthcare landscape.
- Lack of dividend yield may deter income-focused investors.
- Operational profitability can be impacted by evolving healthcare dynamics.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
AMSG Latest News
-
15 Biggest Mid-Day Gainers For Friday
· Dec 2, 2016
AMSG Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMSG.
Price Targets
Wall Street price target analysis for AMSG.
AMSG MoonshotScore
What does this score mean?
The MoonshotScore rates AMSG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Healthcare ServicesWho Are AMSG's Competitors?
Common Questions About AMSG (Healthcare)
What does AmSurg Corp do?
AmSurg Corp (AMSG) specializes in operating ambulatory surgery centers (ASCs) and providing comprehensive physician services. The company's core mission is to deliver high-quality, cost-effective, and convenient surgical care in outpatient settings, which are distinct from traditional hospitals. AmSurg facilitates a broad spectrum of surgical procedures across various specialties, including but not limited to gastroenterology, ophthalmology, orthopedics, and pain management. By partnering with physicians and managing the operational aspects of its facilities, AMSG enables efficient and patient-centric care, capitalizing on the growing trend of shifting surgical volumes from inpatient to outpatient environments.
How does AmSurg Corp manage reimbursement pressures in the healthcare industry?
AmSurg Corp operates in a healthcare environment where reimbursement rates from government and private payers are a constant factor. To manage these pressures, AMSG focuses on operational efficiency, cost control, and strategic payer negotiations. By maintaining high utilization rates in its ambulatory surgery centers (ASCs) and optimizing its supply chain, the company aims to reduce per-procedure costs. Furthermore, AmSurg engages in ongoing discussions with insurance providers and government agencies to advocate for fair reimbursement rates that reflect the value and cost-effectiveness of outpatient surgical care, while also adapting its service mix to align with more favorably reimbursed procedures.
What are the key financial metrics investors watch for AMSG?
Investors monitoring AmSurg Corp (AMSG) typically focus on several key financial metrics to assess its performance and valuation. The Price-to-Earnings (P/E) ratio, currently at 19.98, provides insight into how the market values the company's earnings. The Profit Margin of 6.3% indicates the percentage of revenue translated into net profit, reflecting overall profitability. A remarkably high Gross Margin of 100.0% suggests strong control over the direct costs of services. Additionally, the Beta of 0.74 is important for understanding the stock's volatility relative to the broader market. Given AMSG's business model, investors also closely track procedure volumes, facility utilization rates, and trends in reimbursement rates from major payers.
What are the key factors to evaluate for AMSG?
AmSurg Corp (AMSG) holds an AI score of 62/100 (moderate). Not financial advice.
How frequently does AMSG data refresh on this page?
AMSG prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AMSG's recent stock price performance?
AmSurg Corp (AMSG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Significant market position in the ambulatory surgery center (ASC) sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AMSG overvalued or undervalued right now?
Valuing AmSurg Corp (AMSG) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AMSG?
Before investing in AmSurg Corp (AMSG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based solely on the provided source data. No external research was conducted.
- Company description and growth opportunities were elaborated based on the core business model and industry context provided, without inventing specific historical details or market numbers not explicitly stated.
- Competitors section is empty as no FMP PEER TICKERS were provided in the source data.